These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 21599837

  • 1. The pharmacological effect of positive KCNQ (Kv7) modulators on dopamine release from striatal slices.
    Jensen MM, Lange SC, Thomsen MS, Hansen HH, Mikkelsen JD.
    Basic Clin Pharmacol Toxicol; 2011 Nov; 109(5):339-42. PubMed ID: 21599837
    [Abstract] [Full Text] [Related]

  • 2. The KCNQ channel opener retigabine inhibits the activity of mesencephalic dopaminergic systems of the rat.
    Hansen HH, Ebbesen C, Mathiesen C, Weikop P, Rønn LC, Waroux O, Scuvée-Moreau J, Seutin V, Mikkelsen JD.
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1006-19. PubMed ID: 16775195
    [Abstract] [Full Text] [Related]

  • 3. Involvement of KCNQ2 subunits in [3H]dopamine release triggered by depolarization and pre-synaptic muscarinic receptor activation from rat striatal synaptosomes.
    Martire M, D'Amico M, Panza E, Miceli F, Viggiano D, Lavergata F, Iannotti FA, Barrese V, Preziosi P, Annunziato L, Taglialatela M.
    J Neurochem; 2007 Jul; 102(1):179-93. PubMed ID: 17437547
    [Abstract] [Full Text] [Related]

  • 4. Antipsychotic-like effect of retigabine [N-(2-Amino-4-(fluorobenzylamino)-phenyl)carbamic acid ester], a KCNQ potassium channel opener, via modulation of mesolimbic dopaminergic neurotransmission.
    Sotty F, Damgaard T, Montezinho LP, Mørk A, Olsen CK, Bundgaard C, Husum H.
    J Pharmacol Exp Ther; 2009 Mar; 328(3):951-62. PubMed ID: 19098162
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Kv7 (KCNQ) channel openers induce hypothermia in the mouse.
    Kristensen LV, Sandager-Nielsen K, Hansen HH.
    Neurosci Lett; 2011 Jan 20; 488(2):178-82. PubMed ID: 21087654
    [Abstract] [Full Text] [Related]

  • 7. Functional effects of the KCNQ modulators retigabine and XE991 in the rat urinary bladder.
    Rode F, Svalø J, Sheykhzade M, Rønn LC.
    Eur J Pharmacol; 2010 Jul 25; 638(1-3):121-7. PubMed ID: 20385123
    [Abstract] [Full Text] [Related]

  • 8. The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain site.
    Padilla K, Wickenden AD, Gerlach AC, McCormack K.
    Neurosci Lett; 2009 Nov 13; 465(2):138-42. PubMed ID: 19733209
    [Abstract] [Full Text] [Related]

  • 9. Sequence determinants of subtype-specific actions of KCNQ channel openers.
    Wang AW, Yang R, Kurata HT.
    J Physiol; 2017 Feb 01; 595(3):663-676. PubMed ID: 27506413
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation.
    Dost R, Rostock A, Rundfeldt C.
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Apr 01; 369(4):382-90. PubMed ID: 15007538
    [Abstract] [Full Text] [Related]

  • 12. The pan-Kv7 (KCNQ) Channel Opener Retigabine Inhibits Striatal Excitability by Direct Action on Striatal Neurons In Vivo.
    Hansen HH, Weikop P, Mikkelsen MD, Rode F, Mikkelsen JD.
    Basic Clin Pharmacol Toxicol; 2017 Jan 01; 120(1):46-51. PubMed ID: 27377794
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Kv7 channels in the nucleus accumbens are altered by chronic drinking and are targets for reducing alcohol consumption.
    McGuier NS, Griffin WC, Gass JT, Padula AE, Chesler EJ, Mulholland PJ.
    Addict Biol; 2016 Nov 01; 21(6):1097-1112. PubMed ID: 26104325
    [Abstract] [Full Text] [Related]

  • 15. The KCNQ channel activator retigabine blocks haloperidol-induced c-Fos expression in the striatum of the rat.
    Mikkelsen JD.
    Neurosci Lett; 2004 May 27; 362(3):240-3. PubMed ID: 15158023
    [Abstract] [Full Text] [Related]

  • 16. KCNQ/Kv7 channel regulation of hippocampal gamma-frequency firing in the absence of synaptic transmission.
    Piccinin S, Randall AD, Brown JT.
    J Neurophysiol; 2006 May 27; 95(5):3105-12. PubMed ID: 16467425
    [Abstract] [Full Text] [Related]

  • 17. Activation of KCNQ channels located on the skeletal muscle membrane by retigabine and its influence on the maximal muscle force in rat muscle strips.
    Zagorchev P, Apostolova E, Kokova V, Peychev L.
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr 27; 389(4):439-46. PubMed ID: 26815201
    [Abstract] [Full Text] [Related]

  • 18. KCNQ (Kv7) potassium channel activators as bronchodilators: combination with a β2-adrenergic agonist enhances relaxation of rat airways.
    Brueggemann LI, Haick JM, Neuburg S, Tate S, Randhawa D, Cribbs LL, Byron KL.
    Am J Physiol Lung Cell Mol Physiol; 2014 Mar 15; 306(6):L476-86. PubMed ID: 24441871
    [Abstract] [Full Text] [Related]

  • 19. Increased susceptibility to acetylcholine in the entorhinal cortex of pilocarpine-treated rats involves alterations in KCNQ channels.
    Maslarova A, Salar S, Lapilover E, Friedman A, Veh RW, Heinemann U.
    Neurobiol Dis; 2013 Aug 15; 56():14-24. PubMed ID: 23583611
    [Abstract] [Full Text] [Related]

  • 20. KCNQ3 is the principal target of retigabine in CA1 and subicular excitatory neurons.
    Varghese N, Lauritano A, Taglialatela M, Tzingounis AV.
    J Neurophysiol; 2021 Apr 01; 125(4):1440-1449. PubMed ID: 33729829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.